Analytica Program Reveals Insights Into PeriCoach User Information

Analytica (ASX: ALT) post-market surveillance program reveals insights into PeriCoach user demographics, behaviour and motivation factors. This data adds to the clinical and marketing evidence being accumulated by Analytica for the goal of a licensing deal.

KEY TAKEAWAYS:

• 70% of regular respondents with ‘severe’ incontinence improved to ‘moderate’ or better after using PeriCoach.
• Consistent use key to improvements in quality of life.
• Patient’s severity at onset influences exercise behaviour.
• Clinician recommendation influences purchase, women prefer self-management.

“PeriCoach user surveys are conducted every 6 months as part of Analytica’s post-market surveillance programme. A post-market surveillance programme is required by all Class II medical device manufacturers and is intended to actively solicit feedback from medical device stakeholders. Analytica uses this patient contact event to gather additional voluntary and anonymised information from users on symptoms, and experience, as well as identify opportunities for product development.”

“The responses validate many of the assumptions on which Analytica bases the PeriCoach model, particularly the usage frequency required and the influence of clinicians on the purchasing decision.”

“Quality of life survey categories include the specific areas of social engagement, mood, ability to stay active and fit, and sexual function, in addition to an overall quality of life index. Those women exercising ‘regularly’ with PeriCoach (3-4 times per week) reported improvements of: 27% social engagement, 48% mood, 47% sexual function, 33% ability to stay fit, and 47% overall quality of life. Furthermore, women using the PeriCoach ‘consistently’ (5 or more sessions a week), report an additional improvement 14% in all categories over ‘regular’ users. Consistency matters, with the 30% of respondents whose exercise ‘varies weekly’ achieving only half the improvement of the ‘regular’ users. The benefits of consistent use are clear and Analytica is directing product development resources to incorporate features that encourage increased exercise frequency.”

Analytica’s lead product is the PeriCoach® System – an e-health treatment system for women who suffer Stress Urinary Incontinence. This affects 1 in 3 women worldwide and is mostly caused by trauma to the pelvic floor muscles as a result of pregnancy, childbirth and menopause. PeriCoach comprises a device, web portal and smartphone app.

Request Information